Therefore, in our study, we conducted a pan-cancer analysis of FDX1 in different cancers based on the data from the most comprehensive databases and also explored the effect of FDX1 in BLCA, ccRCC, and PCa cells for the first time. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.